At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc AMPH highlighted why they remain excited about Baqsimi, the inhaled glucagon product for…
Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid a growing market for glucagon products. With promising sales projections and strategic initiatives, Amphastar aims to capitalize on emerging opportunities in the endocrinology sector for continued growth.
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript March 13, 2024 Clearside Biomedical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Clearside Biomedical Q4 2023 Financial Results and Corporate Update Call. At this […]
Operator: Good afternoon and welcome to the PepGen Conference Call to discuss PepGen s Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments.
Company presentations scheduled at the Locust Walk Stem Cell Conference, April 11, and at the Needham Healthcare Conference, April 13CLEVELAND (BUSINESS WIRE) $ATHX #Athersys Athersys, Inc. (Nasdaq: ATHX) announced today that William (B.J.) Lehmann, President and Chief Operating Officer, will present a corporate.